Preoperative Anemia in the Oncology Population and Associated Mortality
Launched by UNIVERSITY OF CHILE · Apr 7, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into a common problem called anemia, which is when a person doesn’t have enough healthy red blood cells. Anemia is especially common among cancer patients who are preparing for surgery, and it can increase the risk of complications and even death after the operation. The study aims to find out how many cancer patients have anemia before their surgery at the National Cancer Institute in Chile. Researchers will also track how this condition affects patients' health outcomes 30 days, 6 months, and 1 year after surgery.
To be eligible for the trial, participants must be at least 18 years old and scheduled for surgery to treat cancer with the goal of curing it. However, those who are having emergency surgery, received a blood transfusion before their surgery, or do not have a blood test done before the operation cannot take part. Since the trial is not yet recruiting, there is still time to learn more about it and see if it might be right for you or a loved one.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients over 18 years of age
- • Oncologic surgery with curative intent
- Exclusion Criteria:
- • Emergency surgery
- • Patients who received a preoperative transfusion
- • Patients without a preoperative blood count
About University Of Chile
The University of Chile, a leading academic institution in South America, is dedicated to advancing medical research and improving public health through innovative clinical trials. With a strong emphasis on collaboration among multidisciplinary teams, the university leverages its extensive resources and expertise to conduct rigorous and ethically sound studies. By integrating cutting-edge scientific methodologies and fostering partnerships with healthcare providers, the University of Chile aims to contribute valuable insights to the medical community and enhance patient care both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported